Collagen Hydrolysate For Use In Prevention And/Or Treatment Of Post Intensive Care Syndrome (Pics)

Patent No. EP4392050 (titled "Collagen Hydrolysate For Use In Prevention And/Or Treatment Of Post Intensive Care Syndrome (Pics)") was filed by Rousselot on Aug 30, 2023. The application was issued on Feb 12, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FRESENIUS KABI DEUTSCHLANDNov 7, 2025FRESENIUS KABI DEUTSCHLAND

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4392050

ROUSSELOT
Application Number
EP23764306A
Filing Date
Aug 30, 2023
Status
Granted And Under Opposition
Jan 10, 2025
Publication Date
Feb 12, 2025